SCHEMBL514278

SCHEMBL514278

[CH2]S(=O)(=O)Cc1ccc(I)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.38
IDO1 P14902 2/20 0.38
APP P05067 3/20 0.37
CA1 P00915 5/20 0.35
CA2 P00918 5/20 0.35
CA9 Q16790 2/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
PRSS1 P07477 2/20 0.33
PRSS2 P07478 2/20 0.33
PRSS3 P35030 2/20 0.33
FAAH O00519 1/20 0.33
ELANE P08246 1/20 0.33
PRTN3 P24158 1/20 0.33
CA5A P35218 1/20 0.33
DAO P14920 1/20 0.33
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1259830 0.76 KMT2A (0.44) IDO1CA1CA2CA9PRSS1
SCHEMBL1542775 0.76 CA2 (0.60) CYP3A4IDO1APPCA1CA2
SCHEMBL515054 0.76 KMT2A (0.48) CYP3A4IDO1CA1CA2CA9
SCHEMBL514279 0.76 RCE1 (0.38) CYP3A4IDO1APPCA1CA2
SCHEMBL514596 0.76 RECQL (0.47) CYP3A4CA1CA2CA9CA5A
SCHEMBL1354157 0.76 CYP3A4 (0.38) CYP3A4IDO1APPCA1CA2
SCHEMBL2375914 0.76 KMT2A (0.48) CYP3A4IDO1CA1CA2CA9
SCHEMBL3126969 0.76 CA1 (0.40) CYP3A4IDO1APPCA1CA2
SCHEMBL514761 0.75 CA2 (0.58) CA1CA2CA9MMP1MMP2
SCHEMBL4860078 0.74 CA1 (0.39) CYP3A4IDO1APPCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 WO disclosed
WO-2014184071-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 WO disclosed
WO-2014184070-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 WO disclosed
EP-2420493-A1 HALOALKYLSULFONANILIDE DERIVATIVE Nissan Chemical Industries, Ltd. (JP) 2012-02-22 EP disclosed
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-02-02 US disclosed
EP-2336104-A1 ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE Nissan Chemical Industries, Ltd. (JP) 2011-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE CBR3, CBR1, HDHD5 CYP3A4 2169/4885IDO1 2656/4885APP 4785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.